These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21936567)

  • 1. Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.
    Gyenis L; Duncan JS; Turowec JP; Bretner M; Litchfield DW
    J Proteome Res; 2011 Nov; 10(11):4887-901. PubMed ID: 21936567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.
    Duncan JS; Gyenis L; Lenehan J; Bretner M; Graves LM; Haystead TA; Litchfield DW
    Mol Cell Proteomics; 2008 Jun; 7(6):1077-88. PubMed ID: 18258654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2.
    Gyenis L; Kuś A; Bretner M; Litchfield DW
    J Proteomics; 2013 Apr; 81():70-9. PubMed ID: 23017496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells.
    Turowec JP; Duncan JS; French AC; Gyenis L; St Denis NA; Vilk G; Litchfield DW
    Methods Enzymol; 2010; 484():471-93. PubMed ID: 21036246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
    Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
    Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.
    Franchin C; Cesaro L; Salvi M; Millioni R; Iori E; Cifani P; James P; Arrigoni G; Pinna L
    Biochim Biophys Acta; 2015 Jun; 1854(6):609-23. PubMed ID: 25278378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.
    Venerando A; Franchin C; Cant N; Cozza G; Pagano MA; Tosoni K; Al-Zahrani A; Arrigoni G; Ford RC; Mehta A; Pinna LA
    PLoS One; 2013; 8(9):e74232. PubMed ID: 24058532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
    Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase CK2 phosphorylation of SAPS3 subunit increases PP6 phosphatase activity with Aurora A kinase.
    Heo J; Larner JM; Brautigan DL
    Biochem J; 2020 Jan; 477(2):431-444. PubMed ID: 31904830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
    Leung KK; Shilton BH
    Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
    Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
    Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
    Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
    J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2.
    Tapia JC; Bolanos-Garcia VM; Sayed M; Allende CC; Allende JE
    J Cell Biochem; 2004 Apr; 91(5):865-79. PubMed ID: 15034923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.
    Li X; Rao V; Jin J; Guan B; Anderes KL; Bieberich CJ
    J Proteome Res; 2012 Jul; 11(7):3637-49. PubMed ID: 22663298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
    J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase 2 binds and phosphorylates the nucleosome assembly protein-1 (NAP1) in Drosophila melanogaster.
    Li M; Strand D; Krehan A; Pyerin W; Heid H; Neumann B; Mechler BM
    J Mol Biol; 1999 Nov; 293(5):1067-84. PubMed ID: 10547286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.
    Salvi M; Sarno S; Cesaro L; Nakamura H; Pinna LA
    Biochim Biophys Acta; 2009 May; 1793(5):847-59. PubMed ID: 19339213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
    Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
    Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Endogenous Kinase Substrates by Proximity Labeling Combined with Kinase Perturbation and Phosphorylation Motifs.
    Niinae T; Imami K; Sugiyama N; Ishihama Y
    Mol Cell Proteomics; 2021; 20():100119. PubMed ID: 34186244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.